MedTech News
.................... by Andrew Celentano
Zeto Announces FDA 510(k) Clearance of Zeto New Wave™, Advancing Efficiency in Outpatient EEG
RALEIGH, N.C., April 2, 2026 /PRNewswire/ — Zeto, Inc., a medical technology company dedicated to making brain health insights through EEG a foundational vital sign in healthcare, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for Zeto New Wave™, its newest EEG system for outpatient clinics and homes.
MediBeacon secures CE Mark certification for TGFR monitor and sensor
Lumitrace is currently approved in China and the US, with submission to EU regulatory authorities pending.
Restore Robotics wins FDA nod to remanufacture new da Vinci instruments
Restore Robotics announced new FDA 510(k) clearances for the remanufacturing of two Intuitive da Vinci Xi robotic surgical instruments.
Vdyne wins FDA IDE to study tricuspid valve replacement
Vdyne announced today that it received FDA investigational device exemption (IDE) for a pivotal trial evaluating its heart valve system.
Simple blood test could spot dementia years earlier, research shows
A blood test could help identify people at higher risk of cognitive decline years before a traditional diagnosis is possible—according to University of East Anglia research published in the journal Gut Microbes.
FDA grants speedy approval to Eli Lilly’s weight-loss pill for obesity
Federal regulators on Wednesday approved Eli Lilly’s new weight-loss pill, a second daily oral medication to treat obesity and other weight-related conditions.
Smart titanium implant enables rapid bacteria elimination and enhanced bone regeneration
A research team from the Department of Orthopedics and Traumatology, School of Clinical Medicine, LKS Faculty of Medicine at the University of Hong Kong (HKUMed), has developed a titanium implant surface that can be activated by near-infrared (NIR). With just 15 minutes of NIR irradiation, this surface can eliminate 99.94% of Staphylococcus aureus (S. aureus) biofilms without the use of antibiotics, while simultaneously promoting bone-implant fusion.
Digital twin hearts deliver 100% success in arrhythmia trial
Working with “digital twins” of patients’ hearts, doctors have improved cardiac ablation outcomes for patients with life-threatening arrhythmias. In the first clinical trials for cardiac digital twins technology, researchers at Johns Hopkins University created digital replicas of patients’ hearts, then tested procedures on those twins before performing them on the real thing. Working with digital twins resulted in faster and significantly more accurate procedures that reduced recurrences of arrhythmias for patients, compared to traditional methods.